qelbree
Pharmaranks rates Qelbree 3.6/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Qelbree (Viloxazine Hydrochloride) is a norepinephrine reuptake inhibitor used to treat Depression.
Viloxazine Hydrochloride · by Supernus Pharms
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Viloxazine Hydrochloride
- Drug class
- Norepinephrine Reuptake Inhibitor
- Form
- Capsule, extended release
- Strength
- Viloxazine Hydrochloride EQ 100MG Base · Viloxazine Hydrochloride EQ 150MG Base · Viloxazine Hydrochloride EQ 200MG Base
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- depression
- Manufacturer
- Supernus Pharms
- FDA application
- NDA211964
Drug class
May treat (source: NIH RxClass)
Dosage forms
Capsule, extended release
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Qelbree treat?
- Qelbree (Viloxazine Hydrochloride) may be used to treat depression, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Qelbree rated?
- pharmaranks gives Qelbree a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Qelbree?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Qelbree. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Qelbree?
- Qelbree is marketed by Supernus Pharms. You can see Supernus Pharms's full profile, rating, and other products on pharmaranks.
- Is Qelbree a brand-name or generic drug?
- Qelbree is a brand-name product with the active ingredient Viloxazine Hydrochloride.
- Is Qelbree available over the counter?
- No. Qelbree is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Qelbree come in?
- Qelbree is currently marketed as capsule, extended release, per the FDA's National Drug Code Directory.
- What class of drug is Qelbree?
- Qelbree is classified as norepinephrine reuptake inhibitor, per the FDA's Established Pharmacologic Class.
- Is Qelbree FDA-registered?
- Qelbree is on record with the U.S. FDA under application number NDA211964. You can verify this on its official FDA label.
- Has Qelbree been recalled by the FDA?
- Qelbree has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Qelbree safe?
- There's no single safe-or-not verdict. pharmaranks gives Qelbree a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about VILOXAZINE HYDROCHLORIDE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 13 reports naming VILOXAZINE HYDROCHLORIDE — the active ingredient in Qelbree, and the FDA flagged 77% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- somnolence4 reports
- hyponatraemia3 reports
- schizophrenia, paranoid type3 reports
- weight increased3 reports
- abortion induced2 reports
- blood alkaline phosphatase increased2 reports
- confusional state2 reports
- disorientation2 reports
Read these as a signal, not a rate. A report does not mean VILOXAZINE HYDROCHLORIDE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Qelbree head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
qelbree
72/100